Tuesday, October 15, 2013

AstraZeneca buys oncology-focused Spirogen for up to $440 million

Retweeted Medical News (@MedicalNews): AstraZeneca to buy oncology-focused Spirogen for up to $440 million http://t.co/eeYdWRMsRl

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/eeYdWRMsRl

No comments:

Post a Comment